Intravenous Therapy and Vein Access Market sizeย was valued at $22.8 billion in 2020, and is estimated to reach $37.5 billion by 2030, growing at a CAGR of 5.1% from 2021 to 2030.ย (IV) therapy is one of the most frequently used health care therapies. It is performed in emergency response settings, hospitals, clinics, nursing homes, and, at an individual’s home. IV therapy is used for many reasons, including restoration of fluids in dehydrated patients. In patients with severe vomiting and/or diarrhea, especially in children, dehydration can be fast and severe. IV therapy transfers and replaces fluids and electrolytes, providing rest to the digestive system rest.

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :

  • Medtronic Inc
  • Teleflex
  • B. Braun Melunsung
  • terumo corporation
  • AngioDynamics, Inc.
  • Fresenius SE and Co. KGaA.
  • Baxter international plc
  • Pfizer Inc
  • Cardinal Health Inc.
  • smiths medical


๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/2350


๐†๐ž๐ญ ๐”๐ฉ ๐“๐จ ๐Ÿ๐ŸŽ% ๐ƒ๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ, ๐“๐ข๐ฅ๐ฅ ๐ญ๐ก๐ž ๐ƒ๐š๐ญ๐ž ๐Ÿ๐ŸŽ๐ญ๐ก ๐จ๐Ÿ ๐€๐ฎ๐ ๐ฎ๐ฌ๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ.


Intravenous Therapy and Vein Access Market trends are an increase in patients with diabetes, an increase in rates of road accidents, and a surge in the number of surgical procedures are expected to drive the growth of the market. An increase in demand for advanced techniques, including needleless administration of drugs drives the market growth. However, the lack of experienced healthcare professionals restricts the market growth. Some factors that influence the advancement of this market include rise in critical care therapies required by the geriatric population and the rise in healthcare facilities are the key factors anticipating the drive of Intravenous Therapy and Vein Access Market growth.

Another key factor that drives the Intravenous Therapy Industry growth is an increase in demand for IVs as an effective and fast-acting way to administer fluid or medication in an emergency situation and for patients who are unable to take medications orally. Approximately 80% of all patients in hospital settings receive IV therapy.


๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/2350

Depending on the type. the IV catheters segment is classified into peripheral IV catheter, center IV catheter, peripherally inserted central catheter, and others. The IV catheters are the fastest growing product segment, owing to the rise in chronic disease and the increase in geriatric population across the globe.

As per the end-user, the hospital segment held the highest market share, owing to an increase in the use of IV therapy in hospitals,  which includes IV antibiotic treatment, medication for unconscious patients, drugs that cannot be orally administered, interventional radiology, anti-cancer drugs, hemodialysis, repeated blood sample drawings, and blood transfusion. Advancements in technology and investment in hospitals boost the growth of IV therapy and vein access device market.

Region-wise, it is analyzed, North America was the highest Intravenous Therapy and Vein Access Market share in 2020, owing to the advanced healthcare infrastructure and use of the latest equipment with updated technologies. Asia-Pacific is expected to be the fastest-growing region, owing to the demand advanced technologies and an increase in the prevalence of kidney disorders & diabetes.


๐Š๐„๐˜ ๐…๐ˆ๐๐ƒ๐ˆ๐๐†๐’ ๐Ž๐… ๐“๐‡๐„ ๐’๐“๐”๐ƒ๐˜

  • Depending on the type, the IV catheters were the highest contributor to the market in 2020.
  • By application type, medical administration dominated the market in 2020 and is expected to continue this trend during the forecast period.
  • Region-wise, North America garnered the largest revenue share in 2020; however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.


๐Ž๐ญ๐ก๐ž๐ซ ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

Flow Cytometry Market

3D Printing Healthcare Market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Leave a comment

Your email address will not be published. Required fields are marked *